Detection of the BCR/ABL fusion gene in chronic myeloid leukemia by RNA polymerase chain reaction

Abstract

The bcr/abl fusion gene in 20 patients with chronic myeloid leukemia (CML) was detected by RNA polymerase chain reaction, which used mRNA as the starting material to generate cDNA with reverse transcriptase followed by PCR amplification (RNA/PCR). Amplification of a sequence spanning the bcr/abl junction region was achieved by using peripheral blood cells as the sourse of mRNA from all 20 patients with CML, including 3 cases of Ph(-) CML, and cell line K562 was derived from patients with CML. No amplification was seen when mononuclear cells from 3 normal individuals, 2 patients with lymphoma and cell line HL-60 were used. The presence or absence of bcr exon 3 in the fusion mRNA was determined by the size of the amplified fragments. Of the 20 CML patients, 15 showed only the 165-bp amplified band (indicating retention of bcr exon 3), done showed only the 90-bp amplified band, and A showed both 165-bp and 90-bp bands. Both bands Were seen more frequently in blast crisis than in remission and chronic phase.

Keywords

chronic myeloid leukemia / gene rearrangement / polymerase chain reaction

References

[1] LobrovicA, TrainorK J, MorleyA A. Detection of the molecular abnormality in chronic myelogenous leukemia by use of the polymerase chain reaction. Blood, 1988, 722063-2063

[2] HeisterkampN, et al. . Structural organization of the bcr gene and its role in the Ph’ translocation. Nature, 1985, 315550-550

[3] ShtivelmanE, et al. . Fused transcript of abl and bcr gnens in chronic myelogenous leukemia. Nature, 1985, 315550-550

[4] Schaefer-RegokK, et al. . CML patients in blast crisis have breakpoints localized to a specific region of the BCR. Blood, 1987, 70(2): 448-448

[5] DreazenO, BermanM, GaleR P. Molecular abnormalities of bcr and c-abl in chronic myelogenous leukemia. Blood, 1988, 71797-797

[6] LeeM S, et al. . Detection of two alternative bcr-abl mRNA junctions and minimal residual disease in Philadelphia chromosome positive chronic myelogenous leukemia by polymerase chain reaction. Blood, 1989, 73(8): 2165-2165

[7] HookH B. Exelusion of chromosomal mosaicism: Tables of 90%, 95%, and 99% confidence limits and comments on use. Am J Hum Genet, 1977, 2994-94

[8] RothM S, et al. . Detection of Philadelphia chromosome positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia. Blood, 1989, 74882-882

[9] MorganG J, et al. . Polymerase chain reaction for detection of residual leukemia. Lancet, 1989, 1928-928